FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 62135-714 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerChartwell RX, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217337
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (1.2 g/1)
Marketing started20230603
Package count2

External sources

Source: openFDA. Public-domain (CC0).